Adaptive Biotechnologies Corp
ADPTLatest QuantConomy context for ADPT: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Adaptive Biotechnologies Corp
QuantConomy has a structured record for ADPT. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- ADPT
- Name
- Adaptive Biotechnologies Corp
- Coverage
- 3 market/data records
- Sources
- alphavantage fmp alpaca sec nasdaq
Recent signals for ADPT
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| large sale | slightly bearish | 30 | Jul 7, 10:54 PM | ROBINS HARLAN S sold ADPT shares ($5.20M) - 239,351 shares - [very weak slightly bearish signal] |
| standard proposed sale | slightly bearish | 35 | Jun 30, 05:50 AM | SHARON BENZENO filed Form 144 to sell ADPT shares ($3.21M) - 152,931 shares - expected around 6/29/2026 - [weak slightly bearish signal - supply pressure] |
| cluster proposed sale | slightly bearish | 31 | Jun 26, 09:50 PM | Cluster of 2 Form 144 filings for ADPT - total $96700.26M proposed sales - 12871 shares - expected around 6/26/2026 - [very weak slightly bearish signal - supply pressure] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PROPOSED_SALE signals are experimental: historical Form 144 coverage is still being backfilled, so results may be sparse or empty.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| ADPT | NASDAQ | alphavantage | Adaptive Biotechnologies Corp |
| ADPT | NASDAQ | fmp | Adaptive Biotechnologies Corporation |
| ADPT | NASDAQ | alpaca | Adaptive Biotechnologies Corporation Common Stock |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | ROBINS HARLAN S | Chief Scientific Officer | sale | 239,351 | $21.74 | $5,203,491 | 4 on EDGAR |
| Jul 1, 2026 | LO FRANCIS | Chief People Officer | exercise | 3,500 | $7.80 | $27,300 | 4 on EDGAR |
| Jul 1, 2026 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | sale | 487 | $22.00 | $10,714 | 4 on EDGAR |
| Jun 26, 2026 | BENZENO SHARON | Chief Commercial Ofc Imm Med | exercise | 11,034 | $12.14 | $133,953 | 4 on EDGAR |
| Jun 25, 2026 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | sale | 5,000 | $20.50 | $102,500 | 4 on EDGAR |
| Jun 25, 2026 | GRIFFIN MICHELLE RENEE | Insider | exercise | 52,084 | $7.80 | $406,255 | 4 on EDGAR |
| Jun 15, 2026 | ROBINS HARLAN S | Chief Scientific Officer | sale | 100,000 | $17.37 | $1,737,000 | 4 on EDGAR |
| Jun 11, 2026 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | sale | 5,000 | $19.00 | $95,000 | 4 on EDGAR |
| Jun 4, 2026 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | sale | 11,000 | $18.00 | $198,000 | 4 on EDGAR |
| Jun 4, 2026 | LO FRANCIS | Chief People Officer | exercise | 5,792 | $12.14 | $70,315 | 4 on EDGAR |
| May 18, 2026 | PISKEL KYLE | Chief Financial Officer | sale | 3,115 | $13.04 | $40,620 | 4 on EDGAR |
| Apr 27, 2026 | RUBINSTEIN JULIE | President and COO | exercise | 14,707 | $8.46 | $124,421 | 4 on EDGAR |
| Apr 22, 2026 | RUBINSTEIN JULIE | President and COO | exercise | 14,722 | $8.46 | $124,548 | 4 on EDGAR |
| Apr 17, 2026 | RUBINSTEIN JULIE | President and COO | exercise | 14,722 | $8.46 | $124,548 | 4 on EDGAR |
| Apr 14, 2026 | RUBINSTEIN JULIE | President and COO | exercise | 14,722 | $8.46 | $124,548 | 4 on EDGAR |
| Apr 9, 2026 | RUBINSTEIN JULIE | President and COO | exercise | 14,722 | $7.27 | $107,029 | 4 on EDGAR |
| Apr 8, 2026 | LO FRANCIS | Chief People Officer | exercise | 2,344 | $3.99 | $9,353 | 4 on EDGAR |
| Apr 8, 2026 | ROBINS HARLAN S | Chief Scientific Officer | sale | 10,000 | $14.85 | $148,500 | 4 on EDGAR |
| Apr 6, 2026 | ROBINS CHAD M | CEO and Chairman | sale | 83,332 | $14.41 | $1,200,814 | 4 on EDGAR |
| Apr 6, 2026 | RUBINSTEIN JULIE | President and COO | exercise | 14,722 | $7.27 | $107,029 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query ADPT context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access